The Risk for Prostate Cancer With Calcium Channel Blockers: A Systematic Review, Meta-Analysis, and Meta-Regression.

Victoria Rotshild Natalie RabkinIlan Matok

Published in: The Annals of pharmacotherapy (2022)

CCBs are an important modality in treating hypertension. The 5% increased risk observed in the current meta-analysis could be influenced by residual confounding factors and should not affect hypertension treatment guidelines until more studies provide additional clinical information.

Keyphrases

systematic review
prostate cancer
blood pressure
case control
meta analyses
radical prostatectomy
healthcare
randomized controlled trial
clinical practice
angiotensin converting enzyme
combination therapy
health information
breast cancer risk